Medyria
Medyria commercializes blood flow velocity sensing technology for the medical field. The company sells its sensors as OEM components and has developed the PyCath, a stand-alone medical device for full physiological assessment in interventional cardiology. Its products target clinical needs related to Angina pectoris and coronary artery disease.
Visit websiteZurich, Switzerland
Healthtech
Medical Devices
Cardiology
Funding summary
- Total raised
- €5.3M
- Funding rounds
- 2
Investors in Medyria
Investors on record for Medyria. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Medyria?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors